Mintz has advised Elicio Therapeutics. Alston & Bird has advised the placement agents. Elicio Therapeutics (Nasdaq: ELTX) (“Elicio”), a clinical-stage biotechnology company, has announced the closing…
Elicio Therapeutics Closes $15 Million Registered Direct Offering

























